Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation
Digestive Diseases · 23.05.2024 · 42 (5) · 461-472
DOI: 10.1159/000538788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases, online erschienen am 23.05.2024. Verfasst von Muzaffer Reha Ümütlü und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University Hospital, LMU Munich, Munich, Germany, muzaffer.uemuetlue@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Introduction
CT-guided interstitial brachytherapy (iBT) radiotherapy has been established in the treatment of liver tumors. With iBT, hepatocellular carcinoma (HCC) lesions can be treated beyond the limits of thermal ablation (i.e., size and location). However, a comprehensive analysis of the efficacy of iBT in patients within and beyond thermal ablation limits is lacking. Materials and Methods: A total of 146 patients with 216 HCC lesions have been analyzed retrospectively. Clinical and imaging follow-up data has been collected. Lesions were evaluated in terms of suitability for thermal ablation or not. The correlation between local tumor control (LTC), time to progression (TTP), overall survival (OS), and clinical and imaging parameters have been evaluated using univariable and multivariable Cox regression analyses.
Results
LTC rates at 12 months, 24 months, and 36 months were 87%, 75%, and 73%, respectively. 65% of lesions (n = 141) were not suitable for radiofrequency ablation (RFA). The median TTP was 13 months, and the median OS was not reached (3-year OS rate: 70%). No significant difference in LTC, TTP, or OS regarding RFA suitability existed. However, in the overall multivariable analysis, lesion diameter >5 cm was significantly associated with lower LTC (HR: 3.65, CI [1.60–8.31], p = 0.002) and shorter TTP (HR: 2.08, CI [1.17–3.70], p = 0.013). Advanced BCLC stage, Child-Pugh Stage, and Hepatitis B were associated with shorter OS. Conclusion: iBT offers excellent LTC rates and OS in local HCC treatment regardless of the limits of thermal ablation, suggesting further evidence of its alternative role to thermal ablation in patients with early-stage HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, University Hospital, LMU Munich, Munich, Germany, muzaffer.uemuetlue@med.uni-muenchen.de.
- Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
- Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
- Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
Zitieren
APA
Ümütlü, M. R., Öcal, O., Puhr-Westerheide, D., Fabritius, M. P., Wildgruber, M., Deniz, S., Corradini, S., Rottler, M., Walter, F., Rogowski, P., Seidensticker, R., Philipp, A. B., Rössler, D., Ricke, J., & Seidensticker, M. (2024). Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation. Digestive Diseases, 42(5), 461-472. https://doi.org/10.1159/000538788
Vancouver
Ümütlü MR, Öcal O, Puhr-Westerheide D, Fabritius MP, Wildgruber M, Deniz S, et al. Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation. Digestive Diseases. 2024;42(5):461-472. doi:10.1159/000538788
BibTeX
@article{mtl2024,
author = {Ümütlü, Muzaffer Reha and Öcal, Osman and Puhr-Westerheide, Daniel and Fabritius, Matthias P and Wildgruber, Moritz and Deniz, Sinan and Corradini, Stefanie and Rottler, Maya and Walter, Franziska and Rogowski, Paul and Seidensticker, Ricarda and Philipp, Alexander B and Rössler, Daniel and Ricke, Jens and Seidensticker, Max},
title = {Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation},
journal = {Digestive Diseases},
year = {2024},
volume = {42},
number = {5},
pages = {461--472},
doi = {10.1159/000538788}
}
EUVIMED